Genomma Targets Prestige’s Objections To Takeover
This article was originally published in The Tan Sheet
Executive Summary
Genomma Lab shareholders approve an unsolicited bid for Prestige Brands with permission to up the ante. In another development that comes as Prestige closes the acquisition of 17 OTC brands from GSK, Prestige acknowledges Genomma’s slate of board nominees to be voted on at a June 29 shareholder meeting.